相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway
Huanzhou Xu et al.
VIROLOGY (2022)
Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients
Tamara S. Rodrigues et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
NINJ1 mediates plasma membrane rupture during lytic cell death
Nobuhiko Kayagaki et al.
NATURE (2021)
Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison
Ioanna-Evdokia Galani et al.
NATURE IMMUNOLOGY (2021)
Human NLRP1 is a sensor for double-stranded RNA
Stefan Bauernfried et al.
SCIENCE (2021)
Diverse viral proteases activate the NLRP1 inflammasome
Brian Tsu et al.
ELIFE (2021)
The right place for IL-1 inhibition in COVID-19
Giulio Cavalli et al.
LANCET RESPIRATORY MEDICINE (2021)
COVID-19 and the human innate immune system
Joachim L. Schultze et al.
CELL (2021)
SARS-CoV-2 Triggers an MDA-5-Dependent Interferon Response Which Is Unable To Control Replication in Lung Epithelial Cells
Antoine Rebendenne et al.
JOURNAL OF VIROLOGY (2021)
Cell entry by SARS-CoV-2
Ruchao Peng et al.
TRENDS IN BIOCHEMICAL SCIENCES (2021)
Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?
Ivan Zanoni
CURRENT OPINION IN VIROLOGY (2021)
Virus-mediated inactivation of anti-apoptotic Bcl-2 family members promotes Gasdermin-E-dependent pyroptosis in barrier epithelial cells
Megan H. Orzalli et al.
IMMUNITY (2021)
Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients
Rutger Koning et al.
INTENSIVE CARE MEDICINE (2021)
Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1
Paul Bastard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Inhibitors of Coronavirus 3CL Proteases Protect Cells from Protease-Mediated Cytotoxicity
Samuel J. Resnick et al.
JOURNAL OF VIROLOGY (2021)
DPP9 sequesters the C terminus of NLRP1 to repress inflammasome activation
L. Robert Hollingsworth et al.
NATURE (2021)
Gasdermin E permits interleukin-1 beta release in distinct sublytic and pyroptotic phases
Bowen Zhou et al.
CELL REPORTS (2021)
Co-regulation and function of FOXM1/RHNO1 bidirectional genes in cancer
Carter J. Barger et al.
ELIFE (2021)
Pathogenic ubiquitination of GSDMB inhibits NK cell bactericidal functions
Justin M. Hansen et al.
CELL (2021)
Shigella ubiquitin ligase IpaH7.8 targets gasdermin D for degradation to prevent pyroptosis and enable infection
Giovanni Luchetti et al.
CELL HOST & MICROBE (2021)
Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19
Monique G. P. van der Wijst et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Autoantibodies neutralizing type I IFNs are present in ∼4% of uninfected individuals over 70 years old and account for ∼20% of COVID-19 deaths
Paul Bastard et al.
SCIENCE IMMUNOLOGY (2021)
X-linked recessive TLR7 deficiency in ∼1% of men under 60 years old with life-threatening COVID-19
Takaki Asano et al.
SCIENCE IMMUNOLOGY (2021)
The first 12 months of COVID-19: a timeline of immunological insights
Thiago Carvalho et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Victor M. Corman et al.
EUROSURVEILLANCE (2020)
Type III interferons: Balancing tissue tolerance and resistance to pathogen invasion
Achille Broggi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
An Infectious cDNA Clone of SARS-CoV-2
Xuping Xie et al.
CELL HOST & MICROBE (2020)
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis
Zhaohai Zheng et al.
JOURNAL OF INFECTION (2020)
Severe Covid-19
David A. Berlin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection
Hanny Al-Samkari et al.
BLOOD (2020)
Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19
Jeremy K. Y. Yap et al.
JOURNAL OF IMMUNOLOGY (2020)
Caspase-1 cleaves Bid to release mitochondrial SMAC and drive secondary necrosis in the absence of GSDMD
Rosalie Heilig et al.
LIFE SCIENCE ALLIANCE (2020)
A minimal common outcome measure set for COVID-19 clinical research
J. C. Marshall et al.
LANCET INFECTIOUS DISEASES (2020)
Longitudinal analyses reveal immunological misfiring in severe COVID-19
Carolina Lucas et al.
NATURE (2020)
Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19
Raphael Cauchois et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jerome Hadjadj et al.
SCIENCE (2020)
Enteroviral 3C protease activates the human NLRP1 inflammasome in airway epithelia
Kim S. Robinson et al.
SCIENCE (2020)
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Qian Zhang et al.
SCIENCE (2020)
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Paul Bastard et al.
SCIENCE (2020)
Irgm2 and Gate-16 cooperatively dampen Gram-negative bacteria-induced caspase-11 response
Elif Eren et al.
EMBO REPORTS (2020)
The trinity of COVID-19: immunity, inflammation and intervention
Matthew Zirui Tay et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Functional degradation: A mechanism of NLRP1 inflammasome activation by diverse pathogen enzymes
Andrew Sandstrom et al.
SCIENCE (2019)
N-terminal degradation activates the NLRP1B inflammasome
Ashley J. Chui et al.
SCIENCE (2019)
Degradation of proteins with N-terminal glycine
Mohamed Eldeeb et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)
The NLRP1 inflammasome: new mechanistic insights and unresolved mysteries
Patrick S. Mitchell et al.
CURRENT OPINION IN IMMUNOLOGY (2019)
Influenza restriction factor MxA functions as inflammasome sensor in the respiratory epithelium
SangJoon Lee et al.
SCIENCE IMMUNOLOGY (2019)
DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia
Darren C. Johnson et al.
NATURE MEDICINE (2018)
Human DPP9 represses NLRP1 inflammasome and protects against autoinflammatory diseases via both peptidase activity and FIIND domain binding
Franklin L. Zhong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Inhibition of Dpp8/9 Activates the Nlrp1b Inflammasome
Marian C. Okondo et al.
CELL CHEMICAL BIOLOGY (2018)
Enterovirus 71 Inhibits Pyroptosis through Cleavage of Gasdermin D
Xiaobo Lei et al.
JOURNAL OF VIROLOGY (2017)
Pyroptosis and Apoptosis Pathways Engage in Bidirectional Crosstalk in Monocytes and Macrophages
Cornelius Y. Taabazuing et al.
CELL CHEMICAL BIOLOGY (2017)
A Modular Assembly Platform for Rapid Generation of DNA Constructs
Elliot H. Akama-Garren et al.
SCIENTIFIC REPORTS (2016)
Functional and Evolutionary Analyses Identify Proteolysis as a General Mechanism for NLRP1 Inflammasome Activation
Joseph Chavarria-Smith et al.
PLOS PATHOGENS (2016)
Inflammasomes: mechanism of assembly, regulation and signalling
Petr Broz et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling
Nobuhiko Kayagaki et al.
NATURE (2015)
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Jianjin Shi et al.
NATURE (2015)
Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
Alvin Lu et al.
CELL (2014)
The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation
Bernardo S. Franklin et al.
NATURE IMMUNOLOGY (2014)
Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana et al.
NATURE METHODS (2014)
Coronavirus 3CLpro proteinase cleavage sites:: Possible relevance to SARS virus pathology -: art. no. 72
L Kiemer et al.
BMC BIOINFORMATICS (2004)
Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs
K Anand et al.
SCIENCE (2003)